Andreas Busch, Chief Innovation Officer at Cyclerion Therapeutics, Inc. (CYCN), bought 125,000 shares at $1.82 ($228K) on 2019-11-15, disclosed to the SEC on 2019-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CYCN | BUY | 2020-11-12 | $316K | — | Filing → |